BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33664229)

  • 1. Small intestinal immune-environmental changes induced by oral tolerance inhibit experimental atopic dermatitis.
    Um HN; Baek JO; Park S; Lee EH; Jang J; Park WJ; Roh JY; Jung Y
    Cell Death Dis; 2021 Mar; 12(3):243. PubMed ID: 33664229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral tolerance inhibits atopic dermatitis-like type 2 inflammation in mice by modulating immune microenvironments.
    Baek JO; Roh JY; Jung Y
    Allergy; 2017 Mar; 72(3):397-406. PubMed ID: 27325577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral tolerance modulates the skin transcriptome in mice with induced atopic dermatitis.
    Baek JO; Lee JR; Roh JY; Jung Y
    Allergy; 2018 Apr; 73(4):962-966. PubMed ID: 29168893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin Ameliorates Ovalbumin-Induced Atopic Dermatitis and Blocks the Progression of Atopic March in Mice.
    Sharma S; Sethi GS; Naura AS
    Inflammation; 2020 Feb; 43(1):358-369. PubMed ID: 31720988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin.
    Katagiri K; Arakawa S; Hatano Y; Fujiwara S
    Arch Dermatol Res; 2008 Nov; 300(10):583-93. PubMed ID: 18528699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A legume product fermented by Saccharomyces cerevisiae modulates cutaneous atopic dermatitis-like inflammation in mice.
    Yeh CY; Jung CJ; Huang CN; Huang YC; Lien HT; Wang WB; Wang LF; Chia JS
    BMC Complement Altern Med; 2014 Jun; 14():194. PubMed ID: 24939647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COX-2 inhibition enhances the TH2 immune response to epicutaneous sensitization.
    Laouini D; Elkhal A; Yalcindag A; Kawamoto S; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2005 Aug; 116(2):390-6. PubMed ID: 16083795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin A deficiency exacerbates extrinsic atopic dermatitis development by potentiating type 2 helper T cell-type inflammation and mast cell activation.
    Yang H; Chen JS; Zou WJ; Tan Q; Xiao YZ; Luo XY; Gao P; Fu Z; Wang H
    Clin Exp Allergy; 2020 Aug; 50(8):942-953. PubMed ID: 32559330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
    Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
    Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (R)-(+)-pulegone suppresses allergic and inflammation responses on 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice model.
    Choi YY; Kim MH; Lee H; Jo SY; Yang WM
    J Dermatol Sci; 2018 Sep; 91(3):292-300. PubMed ID: 29933898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-22 promotes allergic airway inflammation in epicutaneously sensitized mice.
    Leyva-Castillo JM; Yoon J; Geha RS
    J Allergy Clin Immunol; 2019 Feb; 143(2):619-630.e7. PubMed ID: 29920352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin Microbiome in Atopic Dermatitis.
    Edslev SM; Agner T; Andersen PS
    Acta Derm Venereol; 2020 Jun; 100(12):adv00164. PubMed ID: 32419029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD19 expression in B cells regulates atopic dermatitis in a mouse model.
    Yanaba K; Kamata M; Asano Y; Tada Y; Sugaya M; Kadono T; Tedder TF; Sato S
    Am J Pathol; 2013 Jun; 182(6):2214-22. PubMed ID: 23583649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous sensitization with superantigen induces allergic skin inflammation.
    Laouini D; Kawamoto S; Yalcindag A; Bryce P; Mizoguchi E; Oettgen H; Geha RS
    J Allergy Clin Immunol; 2003 Nov; 112(5):981-7. PubMed ID: 14610492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outstanding animal studies in allergy II. From atopic barrier and microbiome to allergen-specific immunotherapy.
    Jensen-Jarolim E; Pali-Schöll I; Roth-Walter F
    Curr Opin Allergy Clin Immunol; 2017 Jun; 17(3):180-187. PubMed ID: 28375932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of kestose on gut mucosal immunity in an atopic dermatitis mouse model.
    Kim HJ; Lee SH; Go HN; Ahn JR; Kim HJ; Hong SJ
    J Dermatol Sci; 2018 Jan; 89(1):27-32. PubMed ID: 29111180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prostaglandin D₂ receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge.
    He R; Oyoshi MK; Wang JY; Hodge MR; Jin H; Geha RS
    J Allergy Clin Immunol; 2010 Oct; 126(4):784-90. PubMed ID: 20713302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flightless I Alters the Inflammatory Response and Autoantibody Profile in an OVA-Induced Atopic Dermatitis Skin-Like Disease.
    Kopecki Z; Stevens NE; Chong HT; Yang GN; Cowin AJ
    Front Immunol; 2018; 9():1833. PubMed ID: 30147695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate-induced mouse atopic-like dermatitis.
    Gaffal E; Glodde N; Jakobs M; Bald T; Tüting T
    Exp Dermatol; 2014 Jun; 23(6):401-6. PubMed ID: 24750433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local but not systemic administration of IFN-gamma during the sensitization phase of protein antigen immunization suppress Th2 development in a murine model of atopic dermatitis.
    Wang LF; Wu JT; Sun CC
    Cytokine; 2002 Aug; 19(3):147-52. PubMed ID: 12242081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.